RTI-122 is a selective, blood-brain barrier-permeable GPR88 agonist (cAMP EC50 = 11 nM), with EC50 values of 11.5 nM and 155 nM for human and mouse GPR88, respectively ([35S]GTPgammaS assay). By activating the GPR88 receptor to regulate the cAMP signaling pathway and G protein activity, RTI-122 significantly attenuates Binge-like drinking, reduces alcohol intake, and decreases alcohol-seeking motivation. RTI-122 blocks the reinstatement of alcohol-seeking behavior without affecting water or sucrose intake. RTI-122 exhibits metabolic stability in mice (T1/2 = 5.8 h) and can be used to investigate alcohol use disorder[1][2].
Molekulargewicht:
491.60
CAS Nummer:
[3034664-39-3]
Formel:
C29H34FN3O3
Target-Kategorie:
GPR88
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
